2020 On-site Forms Industry and Scientific Advisory Board
2020 On-site has formed an Industry and Scientific Advisory Board (IASAB) that will steer its initiatives by gathering insights, sharing ideas, and debating critical business concepts.
The board’s seven members will gather quarterly to identify patient needs, product opportunities and market challenges associated with the provision of vision-related assessments for clinical trials and safety surveillance programs.
On the board are Ms. Jeanne Taylor Hecht, IASAB chair and the founder and CEO of JTH Consulting, LLC; Rajat Agrawal MD, MS, CEO and president of Retina Global; Jeffrey S. Heier, MD, director of the vitreoretinal service and retina research at Ophthalmic Consultants of Boston; Peter K. Kaiser, MD, Chaney Family Endowed Chair in Ophthalmology Research and a professor of ophthalmology at the Cleveland Clinic Lerner College of Medicine; Beth Marsh, vice president of North America Sales and Marketing, Ophthalmology, for Apellis Pharmaceuticals; Jason Menzo, Chief Operating Officer of Foundation Fighting Blindness; and Adam Ramsey, OD, an optometrist and owner of Socialite Vision.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
